• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

is market declining?

Quote

Anonymous

Guest
With lasik and other ways of getting around having to wear contacts or say Rx lenses (eyeglasses) - is there still a good market out there for Rx lenses?
I know part of my responsibilities is market growth; but don't want to work 10x harder because of the market decline.
 




People still need glasses. Even AFTER Lasik. Eventually you age and you will need readers or help EXPECIALLY with that mono vision lasik.

What isn't declining? Is my question to you.....

If you want a cakewalk job go apply to Essilor and sell lenses
 




Top Bottom
Back
Quote